CMS Catches Criticism For Continued Delays With Sunshine Rule
This article was originally published in The Gray Sheet
An agency official refused to say if the rule is imminent during a Sept. 12 roundtable discussion on Capitol Hill on the topic, and would not even confirm that the central data-collection requirements for device and drug companies would begin in 2013.
You may also be interested in...
CMS principal deputy administrator Andy Slavitt steps in as acting administrator as Marilyn Tavenner plans to depart the agency after five years running the agency. She will leave at the end of February.
The latest medical device regulatory and reimbursement news from Elsevier Business Intelligence’s “The Gray Sheet.” This month we cover the post-election picture, pending reimbursement reductions for interventional cardiologists, and new guidance on PMA and 510(k) submission reviews.
Physician Payment Sunshine Act finally goes to OMB. FDA signs regulatory agreements with Brazil, Australia and Canada. More regulatory news.